ALNY - ALNYLAM PHARMACEUTICALS, INC.
320.51
-6.790 -2.118%
Share volume: 1,159,602
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$327.30
-6.79
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-31-2024 | 02-13-2025 | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-12-2026 | |
| Total revenue | 494.333 M | 659.825 M | 500.919 M | 593.166 M | 594.189 M | 773.689 M | 1.249 B | 1.097 B | |
| Cost of revenue | 65.976 M | 68.672 M | 85.905 M | 102.817 M | 71.041 M | 142.953 M | 200.154 M | 267.723 M | |
| Gross profit | 428.357 M | 591.153 M | 415.014 M | 490.349 M | 523.148 M | 630.736 M | 1.049 B | 829.310 M | |
| 38.00% | -29.80% | 18.15% | 6.69% | 20.57% | 66.29% | -20.93% | |||
| Operating expenses | 471.792 M | 542.539 M | 491.919 M | 595.508 M | 505.071 M | 646.935 M | 680.890 M | 697.592 M | |
| Selling general and admin | 210.797 M | 248.397 M | 220.993 M | 295.339 M | 239.949 M | 323.314 M | 322.076 M | 325.374 M | |
| Research and development | 260.995 M | 294.142 M | 270.926 M | 300.169 M | 265.122 M | 323.621 M | 358.814 M | 372.218 M | |
| Total expenses | 471.792 M | 542.539 M | 491.919 M | 595.508 M | 505.071 M | 646.935 M | 680.890 M | 697.592 M | |
| 15.00% | -9.33% | 21.06% | -15.19% | 28.09% | 5.25% | 2.45% | |||
| Operating income | -43.435 M | 48.614 M | -76.905 M | -105.159 M | 18.077 M | -16.199 M | 367.982 M | 131.718 M | |
| Ebit | -57.979 M | -7.091 M | -106.433 M | -186.006 M | -31.623 M | -22.598 M | 293.832 M | 267.171 M | |
| Pretax income | -63.587 M | -11.167 M | -108.663 M | -193.958 M | -41.596 M | -35.358 M | 238.969 M | 161.137 M | |
| -82.44% | 873.07% | 78.49% | -78.55% | -15.00% | -775.86% | -32.57% | |||
| Income tax | 2.348 M | 5.722 M | 2.907 M | -110.195 M | 15.883 M | 30.919 M | -12.115 M | -25.282 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -65.935 M | -16.889 M | -111.570 M | -83.763 M | -57.479 M | -66.277 M | 251.084 M | 186.419 M | |
| 74.39% | -560.61% | 24.92% | 31.38% | -15.31% | 478.84% | -25.75% |